Details for New Drug Application (NDA): 202958
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 202958
Tradename: | LEVETIRACETAM |
Applicant: | Apotex |
Ingredient: | levetiracetam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202958
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 202958
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 202958 | ANDA | Apotex Corp. | 60505-3518 | 60505-3518-6 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-3518-6) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1GM | ||||
Approval Date: | Feb 25, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription